- Home
- ASMB vs DGHI Comparison
ASMB vs DGHI Comparison
Compare ASMB & DGHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- DGHI
- Stock Information
- Founded
- ASMB 2005
- DGHI 2017
- Country
- ASMB United States
- DGHI United States
- Employees
- ASMB N/A
- DGHI N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- DGHI Finance: Consumer Services
- Sector
- ASMB Health Care
- DGHI Finance
- Exchange
- ASMB Nasdaq
- DGHI Nasdaq
- Market Cap
- ASMB 84.5M
- DGHI 90.1M
- IPO Year
- ASMB 2010
- DGHI N/A
- Fundamental
- Price
- ASMB $13.02
- DGHI $2.63
- Analyst Decision
- ASMB Buy
- DGHI Strong Buy
- Analyst Count
- ASMB 2
- DGHI 1
- Target Price
- ASMB $35.00
- DGHI $2.50
- AVG Volume (30 Days)
- ASMB 20.5K
- DGHI 1.0M
- Earning Date
- ASMB 03-27-2025
- DGHI 04-02-2025
- Dividend Yield
- ASMB N/A
- DGHI N/A
- EPS Growth
- ASMB N/A
- DGHI N/A
- EPS
- ASMB N/A
- DGHI N/A
- Revenue
- ASMB $28,326,000.00
- DGHI $42,146,057.00
- Revenue This Year
- ASMB $282.16
- DGHI N/A
- Revenue Next Year
- ASMB N/A
- DGHI N/A
- P/E Ratio
- ASMB N/A
- DGHI N/A
- Revenue Growth
- ASMB N/A
- DGHI 100.56
- 52 Week Low
- ASMB $11.03
- DGHI $0.84
- 52 Week High
- ASMB $19.93
- DGHI $3.77
- Technical
- Relative Strength Index (RSI)
- ASMB 40.89
- DGHI 49.56
- Support Level
- ASMB $12.10
- DGHI $2.81
- Resistance Level
- ASMB $14.25
- DGHI $3.48
- Average True Range (ATR)
- ASMB 0.60
- DGHI 0.46
- MACD
- ASMB -0.10
- DGHI -0.06
- Stochastic Oscillator
- ASMB 35.11
- DGHI 10.24
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About DGHI Digihost Technology Inc. Common Subordinate Voting Shares
Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.